To investigate whether CYA can effectively alleviate ovarian GC pyroptosis and the activation of the IRE1α signaling pathway in PCOS induced by HA, we successfully established mice and cell models of PCOS and CYA treatment groups. The gene discussed is ERN1; the disease is polycystic ovary syndrome.